111 related articles for article (PubMed ID: 37913572)
21. p20BAP31 induces cell apoptosis via both AIF caspase-independent and the ROS/JNK mitochondrial pathway in colorectal cancer.
Jiang X; Li G; Zhu B; Zang J; Lan T; Jiang R; Wang B
Cell Mol Biol Lett; 2023 Mar; 28(1):25. PubMed ID: 36977989
[TBL] [Abstract][Full Text] [Related]
22. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
Fan S; Qi M; Yu Y; Li L; Yao G; Tashiro S; Onodera S; Ikejima T
Free Radic Res; 2012 Mar; 46(3):310-9. PubMed ID: 22283740
[TBL] [Abstract][Full Text] [Related]
23. ROS-mediated JNK pathway critically contributes to PFOS-triggered apoptosis in SH-SY5Y cells.
Sun P; Gu L; Luo J; Qin Y; Sun L; Jiang S
Neurotoxicol Teratol; 2019; 75():106821. PubMed ID: 31401057
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress regulates mitogen‑activated protein kinases and c‑Jun activation involved in heat stress and lipopolysaccharide‑induced intestinal epithelial cell apoptosis.
Liu Y; Wang Z; Xie W; Gu Z; Xu Q; Su L
Mol Med Rep; 2017 Sep; 16(3):2579-2587. PubMed ID: 28656249
[TBL] [Abstract][Full Text] [Related]
25. DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway.
Chang S; Li B; Xie Y; Wang Y; Xu Z; Jin S; Yu D; Wang H; Lu Y; Zhang Y; Ma R; Huang C; Lai W; Wu X; Zhu W; Shi J
Neoplasia; 2022 Jan; 24(1):50-61. PubMed ID: 34890905
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species and c-Jun N-terminal kinases contribute to TEMPO-induced apoptosis in L5178Y cells.
Guo X; Chen S; Zhang Z; Dobrovolsky VN; Dial SL; Guo L; Mei N
Chem Biol Interact; 2015 Jun; 235():27-36. PubMed ID: 25882087
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.
He W; Xu Z; Song D; Zhang H; Li B; Gao L; Zhang Y; Feng Q; Yu D; Hu L; Chen G; Tao Y; Wu X; Shi J; Zhu W
Life Sci; 2020 Feb; 243():117249. PubMed ID: 31926247
[TBL] [Abstract][Full Text] [Related]
28. ROS generation and JNK activation contribute to 4-methoxy-TEMPO-induced cytotoxicity, autophagy, and DNA damage in HepG2 cells.
Zhang Z; Ren Z; Chen S; Guo X; Liu F; Guo L; Mei N
Arch Toxicol; 2018 Feb; 92(2):717-728. PubMed ID: 28993908
[TBL] [Abstract][Full Text] [Related]
29. DHA ameliorates MeHg‑induced PC12 cell apoptosis by inhibiting the ROS/JNK signaling pathway.
Zhang H; Wang S; Wang Y; Lu A; Hu C; Yan C
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109428
[TBL] [Abstract][Full Text] [Related]
30. A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway.
Zhang B; Li B; Xie Y; Chang S; Xu Z; Hu H; Chen G; Zhang T; He J; Wu X; Zhu H; Lai W; Song D; Lu Y; Jia X; Zhu W; Shi J
Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(2):215-224. PubMed ID: 36815376
[TBL] [Abstract][Full Text] [Related]
31. The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.
Dasmahapatra G; Lembersky D; Kramer L; Fisher RI; Friedberg J; Dent P; Grant S
Blood; 2010 Jun; 115(22):4478-87. PubMed ID: 20233973
[TBL] [Abstract][Full Text] [Related]
32. Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency.
Zhou XY; Zhang J; Li Y; Chen YX; Wu XM; Li X; Zhang XF; Ma LZ; Yang YZ; Zheng KM; Liu YD; Wang Z; Chen SL
Oxid Med Cell Longev; 2021; 2021():6634718. PubMed ID: 34367464
[TBL] [Abstract][Full Text] [Related]
33. JNK Activation Contributes to Oxidative Stress-Induced Parthanatos in Glioma Cells via Increase of Intracellular ROS Production.
Zheng L; Wang C; Luo T; Lu B; Ma H; Zhou Z; Zhu D; Chi G; Ge P; Luo Y
Mol Neurobiol; 2017 Jul; 54(5):3492-3505. PubMed ID: 27181592
[TBL] [Abstract][Full Text] [Related]
34. A bis-sulphamoylated estradiol derivative induces ROS-dependent cell cycle abnormalities and subsequent apoptosis.
Visagie MH; van den Bout I; Joubert AM
PLoS One; 2017; 12(4):e0176006. PubMed ID: 28410397
[TBL] [Abstract][Full Text] [Related]
35. Osteocalcin reduces fat accumulation and inflammatory reaction by inhibiting ROS-JNK signal pathway in chicken embryonic hepatocytes.
Zhang M; Tu WJ; Zhang Q; Wu XL; Zou XY; Jiang S
Poult Sci; 2022 Nov; 101(11):102026. PubMed ID: 36174267
[TBL] [Abstract][Full Text] [Related]
36. Triterpene acids from Rosa roxburghii Tratt fruits exert anti-hepatocellular carcinoma activity via ROS/JNK signaling pathway-mediated cell cycle arrest and mitochondrial apoptosis.
Zhai BW; Zhao H; Zhu HL; Huang H; Zhang MY; Fu YJ
Phytomedicine; 2023 Oct; 119():154960. PubMed ID: 37531905
[TBL] [Abstract][Full Text] [Related]
37. The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.
Dasmahapatra G; Patel H; Dent P; Fisher RI; Friedberg J; Grant S
Br J Haematol; 2013 Apr; 161(1):43-56. PubMed ID: 23360303
[TBL] [Abstract][Full Text] [Related]
38. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
39. Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS/JNK Activation.
Wang S; Lin B; Liu W; Wei G; Li Z; Yu N; Xue X; Ji G
Drug Des Devel Ther; 2020; 14():5077-5085. PubMed ID: 33239866
[TBL] [Abstract][Full Text] [Related]
40. Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma.
He Y; Li J; Ding N; Wang X; Deng L; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Song Y; Zhu J
J Exp Clin Cancer Res; 2019 Feb; 38(1):86. PubMed ID: 30777096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
